Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer—results of an exploratory case–control study

PURPOSE: There is growing interest in low-dose metronomic chemotherapy (LDMC) in metastatic breast cancer (MBC). In this retrospective case–control analysis, we compared the efficacy of LDMC and conventional chemotherapy (CCT) in MBC. METHODS: Each LDMC patient receiving oral cyclophosphamide (CTX)...

Descripción completa

Detalles Bibliográficos
Autores principales: Krajnak, S., Schnatz, C., Almstedt, K., Brenner, W., Haertner, F., Heimes, A.-S., Lebrecht, A., Makris, G.-M., Schwab, R., Hasenburg, A., Schmidt, M., Battista, M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297707/
https://www.ncbi.nlm.nih.gov/pubmed/32495001
http://dx.doi.org/10.1007/s10549-020-05711-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297707/
https://www.ncbi.nlm.nih.gov/pubmed/32495001
http://dx.doi.org/10.1007/s10549-020-05711-5

Ejemplares similares